|
RAB30 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.86730000041014E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.284680E-03 |
| Normal-vs-Stage2 |
5.478500E-03 |
| Normal-vs-Stage3 |
8.25929999948016E-07 |
| Normal-vs-Stage4 |
1.09630000000305E-06 |
| Stage1-vs-Stage2 |
4.013800E-01 |
| Stage1-vs-Stage3 |
1.111890E-02 |
| Stage1-vs-Stage4 |
1.115810E-02 |
| Stage2-vs-Stage3 |
5.460600E-01 |
| Stage2-vs-Stage4 |
4.394200E-01 |
| Stage3-vs-Stage4 |
7.729200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.98000000001453E-06 |
| Normal-vs-AfricanAmerican |
1.10570000000365E-06 |
| Normal-vs-Asian |
5.103200E-01 |
| Caucasian-vs-AfricanAmerican |
4.854100E-02 |
| Caucasian-vs-Asian |
4.167000E-01 |
| AfricanAmerican-vs-Asian |
1.298980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.63330000027651E-07 |
| Normal-vs-Female |
1.004930E-03 |
| Male-vs-Female |
9.188000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.302280E-03 |
| Normal-vs-Age(41-60Yrs) |
5.233400E-04 |
| Normal-vs-Age(61-80Yrs) |
4.83360000025357E-07 |
| Normal-vs-Age(81-100Yrs) |
1.321650E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.625600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.892000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.525000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.398000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.549800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.343000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.523640E-01 |
| Normal-vs-Grade 2 |
2.043200E-04 |
| Normal-vs-Grade 3 |
2.79449999995851E-06 |
| Normal-vs-Grade 4 |
6.05579999999328E-05 |
| Grade 1-vs-Grade 2 |
7.126400E-01 |
| Grade 1-vs-Grade 3 |
3.534800E-01 |
| Grade 1-vs-Grade 4 |
3.301800E-01 |
| Grade 2-vs-Grade 3 |
1.481440E-01 |
| Grade 2-vs-Grade 4 |
1.838590E-01 |
| Grade 3-vs-Grade 4 |
7.377800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.219380E-03 |
| Normal-vs-ccB subtype |
3.782100E-04 |
| ccA subtype-vs-ccB subtype |
5.008600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.54989999999944E-05 |
| Normal-vs-N1 |
1.695700E-03 |
| N0-vs-N1 |
3.817200E-01 |
|
|
